期刊文献+

血管生成素1、2及低氧诱导因子1α在烟雾病中的变化及临床意义

Changes of Angiopoietin 1,2 and Hypoxia-Inducible Factor 1α in Patients with Moyamoya Disease and Their Clinical Significance
下载PDF
导出
摘要 目的探讨血清血管生成素1、2(Ang-1、Ang-2)及低氧诱导因子1α(HIF-1α)在烟雾病发生发展中的作用。方法烟雾病患者38例(烟雾病组),健康体检者40例(对照组),采用酶联免疫吸附法检测两组血清Ang-1、Ang-2及HIF-1α浓度。结果烟雾病组Ang-1浓度低于对照组(P<0.05),两组Ang-2、HIF-1α浓度比较,差异无统计学意义(P>0.05);不同性别、不同发病类型的烟雾病患者血清Ang-1、Ang-2及HIF-1α浓度比较,差异均无统计学意义(P>0.05);不同数字减影血管造影(DSA)铃木分期Ang-1、HIF-1α浓度比较,差异有统计学意义(P<0.05),但Ang-2浓度比较,差异无统计学意义(P>0.05)。结论 Ang-1可能参与了烟雾病的发生发展,HIF-1α可能与颅底烟雾病的发生有关。 Objective To investigate the role of serum angiopoietin 1,2( Ang-1,Ang-2) and hypoxia-inducible factor 1α( HIF-1α) in the occurrence and development of moyamoya disease .Methods Thirty-eight cases of moyamoya disease ( moyamoya disease group ) and 40 healthy cases ( control group ) were detected for serum Ang-1,Ang-2 and HIF-1αconcentrations with enzyme-linked immunosorbent assay (ELISA).Results The Ang-1 concentration in moyamoya disease group was lower than the controls (P〈0.05).There was no significant difference in the concentrations of Ang-2, HIF-1αbetween two groups(P〉0.05).The concentrations of Ang-1,Ang-2 and HIF-1αshowed no significant difference among moyamoya disease patients of different genders or different types of the disease ( P〉0.05).The concentrations of Ang-1 and HIF-1αwere associated with disease stages (P〈0.05),while the Ang-2 concentration was not (P〉0.05). Conclusion Ang-1 may be involved in the occurrence and development of moyamoya disease .HIF-1αmay be associated with the occurrence and development of moyamoya disease .
作者 薛胜祥
出处 《广西医学》 CAS 2014年第8期1102-1104,共3页 Guangxi Medical Journal
关键词 烟雾病 血管生成素1 血管生成素2 氧诱导因子1α Moyamoya disease Angiopoietin 1 Angiopoietin 2 Hypoxia-inducible factor 1α
  • 相关文献

参考文献6

二级参考文献63

  • 1赵明光,陈游力,宋振全,高永中,浦佩玉,魏学忠.血管生成因子在脑动静脉血管畸形发生发展过程中的生物学效应[J].中国临床康复,2006,10(6):73-75. 被引量:6
  • 2高山,倪俊,黄家星,黄一宁,汪波.烟雾病临床特点分析[J].中华神经科杂志,2006,39(3):176-179. 被引量:98
  • 3程敬亮,杨运俊,邓军,任翠萍,张焱,韩新巍,李天晓.Moyamoya病CT、MRI和DSA的诊断价值比较[J].郑州大学学报(医学版),2006,41(3):538-541. 被引量:9
  • 4Suzuki J, Takaku A. Cerebrovascula "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain [J]. Archeuro, 1969, 20: 288-299.
  • 5Fukui M. Members of the research committee on spontaneous occlusion of the circle of Willis (Moyamoya 'disease) of the Ministry of Health and Welfare, Japan. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (Moyamoya' disease)[J]. Clin Neurol Neurosurg, 1997, 99 (Suppl 2): 238- 240.
  • 6Takekawa Y, Umezawa T, Ueno Y, et al. Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease[J]. Nettropathology, 2004, 24 (3): 236-242.
  • 7Nishimura M, Ushiyma M, Ohtsuka K, et al. Serum hepatocyte growth factor as a possible indicator of vascular lesions [J]. J Clin Endocrinal Metab, 1999, 84 (11): 2475-2480.
  • 8Maina F, Klein R. Hepatocyte growth factor, a versatile signal for developing neurons[J]. Nat Neurosci, 1999, 2 (3): 213-217.
  • 9Morishita R, Aoki M, Hashiya N, et al. Therapeutic angiogenesis using hepatocyte growth actor (HGF) [J]. Curt Gene Therapy, 2004, 4 (2): 199-206.
  • 10Hayashi T, Abe K, Sakurai M, et al. Inductions of hepatocyte growth factor and its activator in rat brain with permanent middle cerebral artery occlusion[J]. Brain Res, 1998, 799: 311-316.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部